Genome Editing of Mammalian Cells Through RNA Transcript-Mediated Homologous Recombination Repair
Human Gene Therapy · 2024
DOI: 10.1089/hum.2024.025 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Gene Therapy, 2024. Verfasst von Yangmin Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Biosciences and Biopharmaceutics, Guangdong Pharmaceutical University, Guangzhou, People's Republic of China. Hauptthemen laut MEDLINE: Gene Editing, Recombinational DNA Repair, RNA, Guide, CRISPR-Cas Systems, CRISPR-Cas Systems. Die Arbeit nennt 40 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Biosciences and Biopharmaceutics, Guangdong Pharmaceutical University, Guangzhou, People's Republic of China.
- Biopharmaceutical Institute, Guangdong Pharmaceutical University, Guangzhou, People's Republic of China.
ORCID-Profile: Hongwei Shao, Wenfeng Zhang
Zitieren
APA
Wang, Y., Liu, M., Lin, X., Wang, H., Dong, N., Liu, H., Shao, H., & Zhang, W. (2024). Genome Editing of Mammalian Cells Through RNA Transcript-Mediated Homologous Recombination Repair. Human Gene Therapy. https://doi.org/10.1089/hum.2024.025
Vancouver
Wang Y, Liu M, Lin X, Wang H, Dong N, Liu H, et al. Genome Editing of Mammalian Cells Through RNA Transcript-Mediated Homologous Recombination Repair. Human Gene Therapy. 2024. doi:10.1089/hum.2024.025
BibTeX
@article{Wang2024,
author = {Wang, Yangmin and Liu, Meilin and Lin, Xinjian and Wang, Haozheng and Dong, Na and Liu, Hengshen and Shao, Hongwei and Zhang, Wenfeng},
title = {Genome Editing of Mammalian Cells Through RNA Transcript-Mediated Homologous Recombination Repair},
journal = {Human Gene Therapy},
year = {2024},
doi = {10.1089/hum.2024.025}
}
EUVIMED